Stockholders' Equity | (3) Stockholders' Equity Dividends On April 10, 2024, our board of directors declared a quarterly dividend of $0.39 per share of common stock to be paid in cash on May 23, 2024 to shareholders of record at the close of business on April 25, 2024. The following table presents the cash dividends either paid previously or declared by our board of directors for future payment on a per share basis: 2024 2023 First quarter $ 0.39 $ 0.35 Second quarter 0.39 0.35 Third quarter 0.35 Fourth quarter 0.35 Fourth quarter (special) 0.38 Total $ 0.78 $ 1.78 Stock Options The following tables summarize the details of options granted under our stock option plans that were outstanding as of March 31, 2024, and the assumptions used to value those grants. All such grants were effective at the close of business on the date of grant. Options Option Exercise Closing Stock Price on Date March 31, 2024 Date of Grant Options Options January 2, 2024 814,912 $ 64.00 $ 63.550 802,416 50,717 January 3, 2023 1,071,943 $ 48.00 $ 47.400 949,410 205,572 January 3, 2022 713,438 $ 62.00 $ 61.980 583,214 226,398 January 4, 2021 741,510 $ 48.00 $ 47.650 549,094 278,374 January 2, 2020 902,263 $ 38.00 $ 37.230 609,382 395,938 January 2, 2019 1,316,924 $ 26.00 $ 25.705 637,473 493,803 January 2, 2018 1,087,936 $ 27.50 $ 27.270 478,526 401,032 January 3, 2017 1,529,578 $ 23.50 $ 23.475 384,629 340,307 April 19, 2016 1,690,880 $ 23.00 $ 22.870 167,712 111,980 April 21, 2015 1,786,440 $ 21.00 $ 20.630 16,023 16,023 Total 11,655,824 5,177,879 2,520,144 Date of Grant Risk-free Expected Life of Expected Expected Estimated Fair January 2, 2024 3.8 % 5.00 2.2 % 28.44 % $ 15.87 January 3, 2023 4.0 % 5.00 2.6 % 29.58 % $ 11.62 January 3, 2022 1.3 % 5.00 1.7 % 28.52 % $ 13.68 January 4, 2021 0.4 % 5.00 2.0 % 29.17 % $ 9.57 January 2, 2020 1.7 % 5.00 2.4 % 25.70 % $ 6.81 January 2, 2019 2.5 % 5.00 2.9 % 23.96 % $ 4.40 January 2, 2018 2.2 % 5.00 2.3 % 23.45 % $ 5.02 January 3, 2017 1.9 % 5.00 2.6 % 24.49 % $ 4.20 April 19, 2016 1.3 % 5.00 2.6 % 26.34 % $ 4.09 April 21, 2015 1.3 % 5.00 2.7 % 26.84 % $ 3.68 All of the options in the tables above vest and become exercisable over a period of up to eight years. Generally, each option will terminate approximately 10 years after the grant date. The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, net of forfeitures, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected stock volatilities are based on the movement of our stock price over the most recent historical period equivalent to the expected life of the option. Compensation expense equal to the grant date fair value is recognized for all of these awards over the vesting period. The stock-based compensation expense for the three-month periods ended March 31, 2024 and 2023 was $2.0 and $1.9, respectively. Unrecognized stock-based compensation expense related to outstanding unvested stock options as of March 31, 2024 was $24.8 and is expected to be recognized over a weighted average period of 4.62 years. Any future changes in estimated forfeitures will impact this amount. Income Per Share The following tables present a reconciliation of the denominators used in the computation of basic and diluted income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted income per share calculation because they were anti-dilutive: Three-month Period Reconciliation 2024 2023 Basic weighted average shares outstanding 572,339,493 570,928,848 Weighted shares assumed upon exercise of stock options 1,751,214 1,703,741 Diluted weighted average shares outstanding 574,090,707 572,632,589 Three-month Period Summary of Anti-dilutive Options Excluded 2024 2023 Options to purchase shares of common stock 958,569 2,269,908 Weighted average exercise prices of options $ 63.55 52.17 |